Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-02-25 @ 4:39 PM
Study NCT ID:
NCT06525467
Status:
COMPLETED
Last Update Posted:
2024-07-29
First Post:
2024-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Primary Renal Lymphoma on a 48 Year Old Woman
Sponsor:
Instituto Mexicano del Seguro Social
Organization:
Study Overview
Official Title:
Primary Renal Lymphoma: a Case Report and Review of the Literature.
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A 48-year-old female presented to our hospital with the following medical conditions: Systemic arterial hypertension in treatment. She denies any allergies or surgical history.
She reports a history of asthenia and adynamia for 3 months, accompanied by intermittent pain in the left flank. She denies hematuria, fever or weight loss. She underwent an enhanced CT examination at the local hospital, and a mass (10 x 9 cm in diameter) was noted in the left kidney.
She reports a history of asthenia and adynamia for 3 months, accompanied by intermittent pain in the left flank. She denies hematuria, fever or weight loss. She underwent an enhanced CT examination at the local hospital, and a mass (10 x 9 cm in diameter) was noted in the left kidney.
Detailed Description:
She underwent radical nephrectomy and lymph node dissection. with the following surgical findings: (Figure 3) Kidney measuring 7 x 6 x 5 cm, with a tumor located in the upper pole of approximately 12 cm, with abundant newly formed vessels, loose and firm adhesions tumor-spleen and tail of pancreas, 1 artery, 1 vein, 1 ureter.
Postoperative pathology and inmunohistochemistry indicated DLBCL wich only localized in the kidney. Bone marrow biopsy and CT of the chest region dod not show any evidence of linmphoma invasion. According to the findings, she was diagnosed with PRL. After operation the patient received the R-CHOP regimen.
Postoperative pathology and inmunohistochemistry indicated DLBCL wich only localized in the kidney. Bone marrow biopsy and CT of the chest region dod not show any evidence of linmphoma invasion. According to the findings, she was diagnosed with PRL. After operation the patient received the R-CHOP regimen.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: